Galderma Group AG (GDERF)
185.50
-5.68
(-2.97%)
USD |
OTCM |
Sep 15, 16:00
Galderma Group Market Cap : 43.26B for Sept. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 43.26B |
| September 14, 2026 | 44.58B |
| September 11, 2026 | 42.88B |
| September 10, 2026 | 43.61B |
| September 09, 2026 | 47.25B |
| September 08, 2026 | 49.21B |
| September 04, 2026 | 46.17B |
| September 03, 2026 | 46.17B |
| September 02, 2026 | 49.37B |
| September 01, 2026 | 48.27B |
| August 31, 2026 | 48.44B |
| August 28, 2026 | 48.15B |
| August 27, 2026 | 48.04B |
| August 26, 2026 | 52.07B |
| August 25, 2026 | 51.25B |
| August 24, 2026 | 47.98B |
| August 21, 2026 | 51.84B |
| August 20, 2026 | 47.81B |
| August 19, 2026 | 51.02B |
| August 18, 2026 | 49.47B |
| August 17, 2026 | 47.82B |
| August 14, 2026 | 51.86B |
| August 13, 2026 | 49.13B |
| August 12, 2026 | 49.13B |
| August 11, 2026 | 53.30B |
| Date | Value |
|---|---|
| August 10, 2026 | 53.30B |
| August 07, 2026 | 51.29B |
| August 06, 2026 | 50.12B |
| August 05, 2026 | 48.70B |
| August 04, 2026 | 50.31B |
| August 03, 2026 | 48.86B |
| July 31, 2026 | 52.64B |
| July 30, 2026 | 52.47B |
| July 29, 2026 | 52.13B |
| July 28, 2026 | 52.27B |
| July 27, 2026 | 52.47B |
| July 24, 2026 | 49.49B |
| July 23, 2026 | 49.82B |
| July 22, 2026 | 49.62B |
| July 21, 2026 | 48.79B |
| July 20, 2026 | 47.96B |
| July 17, 2026 | 50.75B |
| July 16, 2026 | 50.75B |
| July 15, 2026 | 47.11B |
| July 14, 2026 | 49.26B |
| July 13, 2026 | 47.04B |
| July 10, 2026 | 48.87B |
| July 09, 2026 | 48.94B |
| July 08, 2026 | 48.94B |
| July 07, 2026 | 54.09B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 255.29B |
| Roche Holding AG | 303.33B |
| Addex Therapeutics Ltd. | 3.321M |
| Oculis Holding AG | 601.27M |
| Sandoz Group AG | 34.88B |
Market Cap Related Metrics
| PE Ratio | 50.66 |
| PS Ratio | 7.420 |
| Price to Free Cash Flow | 41.21 |
| Price | 185.50 |
| Earnings Yield | 1.97% |
| Operating PE Ratio | 40.04 |
| Normalized PE Ratio | 47.29 |